Market Cap for IDEXX Laboratories (IDXX)
According to IDEXX Laboratories's latest reported financial statements, the company's latest reported market cap is $54.58B USD. Market capitalization is the total dollar value of all outstanding shares — shares outstanding × stock price — and the standard measure of a company's equity value. On this page, historical market cap snaps filing-period share counts to closing prices on or before each statement date (not intraday tick data).
Headline figure above is from the reporting period ending (reported ). Chart and table below cover the full reported history back to .
Currently viewingMarket CapSwitch metric
Latest period
$54.58B
YoY change
-18.2%
5Y CAGR
-4.8%
Peak year (2021)
$57.00B
Latest annual
$44.67B
Market Cap history chart for IDEXX Laboratories (IDXX) from 1991 to 2026
Market Cap history table for IDEXX Laboratories (IDXX) from 1991 to 2026
| Fiscal year | Period ended | Reported | Market Cap | YoY |
|---|---|---|---|---|
| 2026 | $44.67B | -18.2% | ||
| 2025 | $54.58B | +58.6% | ||
| 2024 | $34.42B | -26.2% | ||
| 2023 | $46.61B | +35.1% | ||
| 2022 | $34.51B | -39.5% | ||
| 2021 | $57.00B | +31.5% | ||
| 2020 | $43.35B | +89.6% | ||
| 2019 | $22.86B | +38.9% | ||
| 2018 | $16.46B | +17.5% | ||
| 2017 | $14.01B | +31.4% | ||
| 2016 | $10.66B | +56.1% | ||
| 2015 | $6.83B | -9.2% | ||
| 2014 | $7.52B | +31.0% | ||
| 2013 | $5.74B | +10.2% | ||
| 2012 | $5.21B | +16.3% | ||
| 2011 | $4.48B | +8.7% | ||
| 2010 | $4.12B | +27.1% | ||
| 2009 | $3.24B | +44.4% | ||
| 2008 | $2.25B | -40.6% | ||
| 2007 | $3.78B | +44.6% | ||
| 2006 | $2.61B | +6.6% | ||
| 2005 | $2.45B | +25.4% | ||
| 2004 | $1.95B | +17.5% | ||
| 2003 | $1.66B | +44.5% | ||
| 2002 | $1.15B | +16.6% | ||
| 2001 | $987.59M | +24.4% | ||
| 2000 | $793.78M | +23.8% | ||
| 1999 | $641.07M | -37.3% | ||
| 1998 | $1.02B | +70.3% | ||
| 1997 | $600.50M | -15.1% | ||
| 1996 | $706.99M | -14.7% | ||
| 1995 | $828.98M | +177.0% | ||
| 1994 | $299.25M | +12.4% | ||
| 1993 | $266.25M | +144.7% | ||
| 1992 | $108.80M | +95.6% | ||
| 1991 | $55.62M | — |
Market Cap values are taken from IDEXX Laboratories's reported income statements (10-Q quarterly and 10-K annual filings with the U.S. Securities and Exchange Commission). Each row shows the period end date and the date the filing was reported; YoY compares each figure to the same period one year earlier. Amounts are in USD as filed.
Analysis
As of the 2026 fiscal year, IDEXX Laboratories (IDXX) reported market cap of $44.67B – declined 18.2% year-over-year.
Through 2021–2026 (5 years), IDEXX Laboratories market cap delivered a -4.8% annualised rate; with a net decline across the window.
IDEXX Laboratories market cap peaked at $57.00B in 2021; the latest annual figure is $44.67B in 2026 (21.6% below peak).
$57.00B stands as the all-time-high annual market cap, posted in 2021, against a low of $55.62M during 1991.
Within Healthcare, IDEXX Laboratories (IDXX) ranks 9th among 8 peers we track. The peer median for market cap is $311.16B.
IDEXX Laboratories Market Cap by Year
IDEXX Laboratories Market Cap 2026: $44.67B
IDEXX Laboratories market cap in 2026 was $44.67B, declined 18.2% below 2025.
IDEXX Laboratories Market Cap 2025: $54.58B
IDEXX Laboratories market cap in 2025 was $54.58B, surged 58.6% from 2024.
IDEXX Laboratories Market Cap 2024: $34.42B
IDEXX Laboratories market cap in 2024 was $34.42B, declined 26.2% below 2023.
IDEXX Laboratories Market Cap 2023: $46.61B
IDEXX Laboratories market cap in 2023 was $46.61B, surged 35.1% from 2022.
IDEXX Laboratories Market Cap 2022: $34.51B
IDEXX Laboratories market cap in 2022 was $34.51B.
See more financial history for IDEXX Laboratories (IDXX).
Sector peers — Market Cap
Companies in the same sector as IDEXX Laboratories, ranked by their latest market cap.
| Company | Market Cap | Sector |
|---|---|---|
| Eli Lilly and Company (LLY) | $825.77B | Healthcare |
| Johnson & Johnson (JNJ) | $548.34B | Healthcare |
| AbbVie Inc. (ABBV) | $349.67B | Healthcare |
| UnitedHealth Group Incorporated (UNH) | $332.91B | Healthcare |
| AstraZeneca PLC (AZN) | $289.41B | Healthcare |
| Merck & Co., Inc. (MRK) | $272.11B | Healthcare |
| Amgen Inc. (AMGN) | $183.05B | Healthcare |
| Novo Nordisk A/S (NVO) | $182.96B | Healthcare |
Frequently asked questions
What is IDEXX Laboratories's market cap?
- Latest reported market cap for IDEXX Laboratories (IDXX) is $54.58B (period ending December 31, 2025).
How has IDEXX Laboratories market cap changed year-over-year?
- IDEXX Laboratories (IDXX) market cap changed -18.2% year-over-year on the latest annual filing.
What is the long-term growth rate of IDEXX Laboratories market cap?
- IDEXX Laboratories (IDXX) market cap compound annual growth rate is -4.8% over the most recent 5 years available.
When did IDEXX Laboratories market cap hit its highest annual value?
- IDEXX Laboratories market cap reached its highest annual value of $57.00B in 2021.
What was IDEXX Laboratories market cap in 2025?
- IDEXX Laboratories (IDXX) market cap in 2025 was $54.58B.
What was IDEXX Laboratories market cap in 2026?
- IDEXX Laboratories (IDXX) market cap in 2026 was $44.67B.
Metrics overview
Pick a metric for charts, filings, and peers — each row shows the latest TTM or annual value with year-over-year change.
Explore more
IDXX Overview
Company profile, financial tools, and key metrics
IDXX Revenue Counter
Earns $136.47 every second. See per minute, hour, and day.
IDXX Earnings Counter
Earns $33.60 per second net profit. See per minute, hour, and day.
IDXX Economic Scale
Exceeds Aruba's GDP. Compare with world economies.
IDXX What If Invested
What if you had invested $1,000? See historical returns from any date.
IDXX How It Makes Money
Discover visual breakdown of $4.30B in revenue — where it comes from and where it goes.
IDXX Stock Seasonality
Best and worst months to invest. Historical monthly returns heatmap.
IDXX Price Target Scenarios
Model bear, base, and bull cases with EPS growth and exit P/E — pre-filled from analysts and history.
IDXX Daily Price Character
Explosive · 50.9% historical win rate (green days). Streaks & record days.
IDXX Buybacks
2.25% TTM buyback yield. Shareholder yield & SBC comparison.
IDXX Stock Split History
4 splits on record. Dates, ratios, and cumulative multiple.